Anti-Doping Agency of Armenia Annual Report 2022 / Anti-Doping Agency of Armenia (ARM-NADO). - Yerevan, ARM-NADO, 2023

Εθνικός Οργανισμός Καταπολέμησης του Ντόπινγκ (EOKAN) Ετήσέιακθεσ 2021 / Hellenic Anti-Doping Agency (HADA). - Maroussi, 2023

2021 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2023

Contents:

• Executive Summary - pp. 2-9 (7 pages)
• Laboratory Report -– pp. 10-39 (30 pages)
• Sport Report - pp. 40-153 (114 pages)
• Testing Authority Report - pp. 154-267 (114 pages)
• ABP Report-Blood Analysis - pp. 268-311 (44 pages)

Report Highlights:

• A 61.2% increase in the number of samples (both urine and non-ABP blood samples) analyzed
  and reported into ADAMS: 149,758 in 2020 to 241,430 in 2021.
• An increase in the total number of samples analyzed and reported by nearly all WADAaccredited
  laboratories and WADA-approved laboratories into ADAMS in 2021 compared to 2020.
• An increase in the total number and percentage of non-ABP blood samples analyzed: 7.3%
  (10,940 of 149,758 samples) in 2020 to 9.3% (22,398 Blood + DBS samples out of 241,430).
• An increase of 36% in the number of ABP blood samples analyzed: 22,666 in 2020 to 30,821
  in 2021.
• A decrease in the total percentage of AAFs: 0.67% in 2020 (1,009 AAFs from 149,758
  samples) to 0.65% (1,560 AAFs from 241,430 samples).
• An increase in the total number of AAFs for growth hormone (GH): 1 in 2020 to 7 in 2021,
  including the first reported AAF for a GH biomarker.
• A 46% decrease in the overall number of samples analyzed: 278,047 in 2019 to 149,758 in 2020.
• A decrease in the total percentage of Adverse Analytical Findings (AAFs): 0.97% in 2019 (2,702 AAFs from 278,047 samples) to 0.67% in 2020 (1,009 AAFs from 149,758 samples).
• All WADA-accredited Laboratories saw a decrease in the total number of samples recorded.
• A decrease in the total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.1% in 2019 (25,339 of 278,047) and 7.3% (10,940 of 149,758) in 2020.
• A decrease of 38% in the number of ABP blood samples tested: 36,401 in 2019 to 22,666 in 2020.

The World Anti-Doping Agency (WADA) has publishes its 2021 Testing Figures Report (2021 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2021.

This is the first set of global testing figures under the 2021 World Anti-Doping Code (Code) that came into effect in January 2021. The 2021 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).

Raport Roczny 2021 / Polska Agencja Antydopigowa (POLADA). - Warszawa : POLADA, 2022

Prohibited List January 2023 : The World Anti-Doping Code International Standard / World Anti-Doping Agency (WADA). - Montreal : WADA, 2022

The Prohibited List is a mandatory International Standard as part of the World Anti-Doping Program.
The List is updated annually following an extensive consultation process facilitated by WADA. The effective date of the List is 01 January 2023.

On 16 June 2022 the Anti-Doping Disciplinary Panel of India (ADDPI) decided to impose a 3 month period of ineligibility on the Athlete M.R. Poovamma after she tested positive for the prohibited substance Methylhexaneamine (dimethylpentylamine) related to the supplement she had used.

Hereafter India National Anti-Doping Agency (INADA) appealed the ADDPI decision with the Anti-Doping Appeal Panel of India (ADAPI). INADA requested the panel to set aside the Appealed Decision and to impose a more sever sanction on the Athlete.

The Athlete denied the intentional use of the substance and argued that she had demonstrated that source of the positive test was an over-the-counter medication she had used. Analysis in a laboratory revealed that the supplement Bedtime Latte contained the prohibited substance.

INADA conteded that the Athlete had acted negligently with her supplements as an experienced athlete and had not established the source of the prohibited substance. She failed to mention all her supplements and medications on the Doping Control, nor made an appliciation for a TUE.

The Panel finds that the presence of a prohibited substance had been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation. The Panel accepts that the violation was not intentional although she had acted negligently.

The Panel considers that the Athlete had not mentioned all her supplements and medication on the Doping Control Form and had not produced corroborating evidence to establish the source of the prohibited substance.

The Panel deems that the laboratory in question was not accredited and their analysis report was insufficient. Moreover the Athlete's tested medication container was delivered open and suspicious and as an experience athlete she had failed to check ther medication before using.

Therefore ADAPI decides on 17 September to set aside the Appealed Decision and to impose a 2 year period of ineligibility on the Athlete.

Annual Report 2021 / Swiss Sport Integrity; Anti-Doping Switzerland. - Bern : Swiss Sport Integrity, 2022

In January 2022 the International Tennis Federation (ITF) has reported an anti-doping rule violation against the Russian tennis player Elizavetka Demina after her A and B samples tested positive for the prohibited substance Meldonium.

After notification the Athlete gave a prompt admission, waived her right for a hearing, accepted the provisional suspension and the decision rendered by the ITF. The Athlete admitted that prior in August 2021 she had used Mildronate over two week in order to recover after a period of intense training.

The ITF finds that the presence of a prohibited substance has been established in the Athlete's samples and accordingly that she committed an anti-doping rule violation. The ITF deems that the Athlete had not attempted to demonstrate that the violation was not intentional and considers that she gave an early admission and acceptance of sanction.

Therefore the ITF decides on 30 March 2022 to impose a 3 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 21 January 2022.